[Antiresorptive-cytokine effects of the chondroprotective therapy in patients with lower back pain].

Published in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2020)

At the end of the study, there is a significant decrease in all studied cytokines in patients of group 1 compared to group 2, as well as indicators of beta-Crosslaps (p<0,001) and DPID (p<0,001), which may indicate the presence of its own antiresorptive-cytokine effect in chondroitin sulfate.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
mesenchymal stem cells
patient reported outcomes